Protocols
1 protocol(s) meet the specified criteria
Drug: Tremelimumab
Protocol No.TitleStatus
GU17-294Phase 2 Trial of Tremelimumab in Patients with Metastatic Urothelial Cancer Previously Treated with PD-1/PD-L1 BlockadeOpen